RHYTHM PHARMACEUTICALS, INC. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Rhythm Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -367 %, a 328% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Return On Equity for 2023 was -96 %, a 29.5% decline from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.2 %, a 257% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Return On Equity for 2021 was -20.8 %, a 67.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -96 -21.9 -29.5% Jan 1, 2023 Dec 31, 2023
2022 -74.2 -53.4 -257% Jan 1, 2022 Dec 31, 2022
2021 -20.8 +42.8 +67.3% Jan 1, 2021 Dec 31, 2021
2020 -63.6 +4.02 +5.94% Jan 1, 2020 Dec 31, 2020
2019 -67.7 -35.9 -113% Jan 1, 2019 Dec 31, 2019
2018 -31.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.